| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.4 |